|
MEDP
|
Medpace Holdings, Inc.
|
5.27%
|
US
|
NASDAQ
|
|
UNH
|
UnitedHealth Group Incorporated
|
5.05%
|
US
|
NYSE
|
|
IDXX
|
IDEXX Laboratories, Inc.
|
4.26%
|
US
|
NASDAQ
|
|
LLY
|
Eli Lilly and Company
|
3.69%
|
US
|
NYSE
|
|
AXSM
|
Axsome Therapeutics, Inc.
|
3.15%
|
US
|
NASDAQ
|
|
PCVX
|
Vaxcyte, Inc.
|
3.01%
|
US
|
NASDAQ
|
|
ELV
|
Elevance Health, Inc.
|
2.96%
|
US
|
NYSE
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
2.95%
|
US
|
NASDAQ
|
|
MTD
|
Mettler-Toledo International, Inc.
|
2.94%
|
US
|
NYSE
|
|
UTHR
|
United Therapeutics Corporation
|
2.88%
|
US
|
NASDAQ
|
|
RYTM
|
Rhythm Pharmaceuticals, Inc.
|
2.70%
|
US
|
NASDAQ
|
|
HCA
|
HCA Holdings, Inc.
|
2.69%
|
US
|
NYSE
|
|
A
|
Agilent Technologies, Inc.
|
2.57%
|
US
|
NYSE
|
|
ABBV
|
AbbVie Inc.
|
2.43%
|
US
|
NYSE
|
|
ISEE
|
IVERIC bio, Inc.
|
2.41%
|
US
|
NASDAQ
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
2.29%
|
US
|
NASDAQ
|
|
AKRO
|
Akero Therapeutics, Inc.
|
2.25%
|
US
|
NASDAQ
|
|
ENSG
|
The Ensign Group, Inc.
|
2.22%
|
US
|
NASDAQ
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
2.13%
|
US
|
NASDAQ
|
|
CPRX
|
Catalyst Pharmaceutical Partners, Inc.
|
2.12%
|
US
|
NASDAQ
|